X0306
4
2018-02-15
0
0001503802
Karyopharm Therapeutics Inc.
KPTI
0001603510
Primiano Christopher Brett
C/O KARYOPHARM THERAPEUTICS INC.
85 WELLS AVENUE
NEWTON
MA
02459
0
1
0
0
EVP, CBO, GC & Secretary
Common Stock
2018-02-15
4
S
0
1014
15.0187
D
8867
D
Common Stock
2018-02-16
4
S
0
1486
15.0054
D
7381
D
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.04, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price.
Represents the weighted average sale price. These shares were sold in transactions at $15.00 and $15.08. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price.
/s/Christopher B. Primiano
2018-02-20